Randomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity
Top Cited Papers
- 17 November 2005
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (20), 2111-2120
- https://doi.org/10.1056/nejmoa050156
Abstract
Weight-loss medications are recommended as an adjunct to a comprehensive program of diet, exercise, and behavior therapy but are typically prescribed with minimal or no lifestyle modification. This practice is likely to limit therapeutic benefits.Keywords
This publication has 24 references indexed in Scilit:
- Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and StrategiesDiabetes Care, 2004
- Short-term effects of sibutramine (ReductilTM) on appetite and eating behaviour and the long-term therapeutic outcomeInternational Journal of Obesity, 2003
- Combining Behavioral and Pharmacological Treatments for ObesityObesity Research, 2002
- ObesityNew England Journal of Medicine, 2002
- Effect of sibutramine on weight maintenance after weight loss: a randomised trialThe Lancet, 2000
- BEHAVIORAL TREATMENT OF OBESITYMedical Clinics of North America, 2000
- Executive SummaryObesity Research, 1998
- Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patientsThe Lancet, 1998
- A Double‐Blind Randomized Placebo‐Controlled Trial of SibutramineObesity Research, 1996
- Behavior Therapy and Pharmacotherapy for ObesityArchives of General Psychiatry, 1981